Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is well-positioned to capitalize on the growing demand for virtual healthcare services and the increasing focus on preventative care. Its innovative Migraine Care Program, strong financial projections, and partnerships with major employers and health plans make it a promising investment option in the rapidly evolving digital health industry. The company's solid financial plan and long-term goals, coupled with its strong market presence, indicate the potential for a positive return for investors in the future.

Bears say

Hinge Health is experiencing strong revenue growth, with a 2026 outlook of 36% above consensus, and is well-positioned for continued growth with multiple revenue tailwinds in 2027 such as yield improvement and new product contributions. With improving margins and an aggressive expansion strategy, it is expected that Hinge Health will continue to gain market share and achieve strong financial results, making it a potentially attractive investment opportunity. However, potential risks such as government regulation, competition, and customer retention could potentially impact the company's growth and profitability in the future.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Jun 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.41, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.41, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.